Nanjing Medical insurance designated retail drugstore starts to implement 4 + 7

On December 23, a personage in the industry disclosed to cypress blue that the designated retail drugstore of medical insurance in Nanjing started to implement 4 + 7 With the implementation of 4 + 7 price, the adjustment of medical insurance payment price is equal to that of all designated retail pharmacies It is reported that from today, the price of 4 + 7 related varieties in Nanjing Medical Insurance retail drugstore has been adjusted to achieve "the same price as the same drug" with the hospital Sepiland exclusively learned that the pharmacy of Jiangsu pharmaceutical company announced today (December 23) that the price of 4 + 7 will be implemented from now on, the price of gefitinib (IRICO) will be adjusted to 257 yuan, and the price of imatinib mesylate (Xinwei) will be adjusted to 623 yuan At present, the price of the above products in the company's store system has been adjusted to be the same as that of the hospital And the sales price shown in the figure below is the maximum amount that the medical insurance can brush If it exceeds this amount, the customer can only pay extra It is understood that in Nanjing, as long as the medical insurance payment price is adjusted, all designated medical insurance institutions in Nanjing will implement the adjusted price At present, Jiangsu People's hospital has also issued a notice, and will follow up the 4 + 7 price on time As early as November 7, nine departments including Jiangsu Medical Security Bureau jointly issued the notice on printing and distributing the implementation plan of Jiangsu Province to promote the implementation of the pilot project of centralized purchase and use of drugs organized by the state to expand the regional scope It is clearly mentioned that Jiangsu Province will fully implement the results of national pilot expansion and various supporting policies before December 31, 2019 From the current situation of hospitals and medical insurance retail pharmacies, it is also in accordance with the prescribed time It is found that there are more than 2000 drugstores in Nanjing City, Jiangsu Province by querying the drugstore database According to 70% of medical insurance drugstores, the number of drugstores involved in the implementation of 4 + 7 also reached more than 1000 Recently, Xi'an Yikang, Shuyu civilian and common people announced to follow up 4 + 7 successively, which is "the same price as the same medicine" with the hospital And Yifeng also issued an "emergency notice" If a patient purchases drugs of the same factory and specification that are lower than the retail price or membership price of Yifeng pharmacy within 2 kilometers, Yifeng will return 3 times the difference of the minimum selling unit price of the drugs once verified The impact of 4 + 7 on the whole pharmaceutical industry is gradually emerging and spreading to the retail market Jia Xiaoqing, the purchasing manager of the retail department of Jiangsu Pharmaceutical Co., Ltd., told saibailan that all medical insurance pharmacies in Nanjing implement 4 + 7, which has a great impact on small and medium-sized chain pharmacies Retail pharmacies will face the problem of how to make up the existing inventory After all, small and medium-sized chains are not as powerful as large-scale chains in bargaining power If the new purchase price is not clear whether it is based on 4 + 7 or the original price, the sudden implementation of 4 + 7 medical insurance price adjustment in Nanjing will catch some retail pharmacies by surprise On the issue of price, he believed that according to the current judgment, the industry should implement the same price of hospital retail If industrial enterprises do not give the same treatment to hospitals and pharmacies, 4 + 7 varieties will disappear in some pharmacies However, since the medical insurance department has chosen to implement the 4 + 7 unified price system inside and outside the hospital, it must be hoped that industrial enterprises can treat small and medium-sized chain stores in the same price way, and truly implement the 4 + 7 program to facilitate the purchase of drugs by patients As for 4 + 7, the first thing you think about is that the price of the hospital is cheaper After the implementation of the 4 + 7 pilot, the difference between the pilot area and the non pilot area of the same kind, as well as the difference between the prices of hospitals and pharmacies in the pilot area, caused the dissatisfaction of many patients It is precisely because of this difference that a large number of patients flock to hospitals in pilot areas to buy drugs, which to a certain extent affects the medical order and drug supply For retail pharmacies, the 4 + 7 pilot brings huge differences in hospital retail, which also causes some problems A pharmaceutical enterprise personage told saibelan that since the previous 4 + 7 pilot retail drugstores were not involved, pharmaceutical enterprises should supply the hospital at the 4 + 7 median price, but the retail channel did not have this requirement, and the medical insurance department did not intervene, resulting in that the 25 selected varieties are difficult to find in the drugstore, and many varieties are in the off shelf state in the retail drugstore Now, with the 4 + 7 expansion and landing, more and more patients can enjoy the most favorable price simultaneously, which is beneficial to the development and progress of the industry, and this trend will continue According to the data of mienei.com, 61 products of 40 pharmaceutical enterprises won the bid in the 4 + 7 pilot and 4 + 7 expansion The proportion of all products in the retail terminal market in 2018 is only 4.2% Generally speaking, the proportion of enterprises winning the bid in the current centralized procurement varieties is relatively small, which has little impact on the retail market.